Composition
- Active ingredients
- DROSPIRENONE 0.5MG; ESTRADIOL 1MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA218031.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Drospirenone and Estradiol
- Active substance
- drospirenone
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Novast Labs
- Status
- Prescription
- FDA approval
- 28 Oct 2025
- Application
- ANDA218031-001